An effective initial polytherapy for children with West syndrome

Area of Science:

• Pediatric Neurology
• Epileptology
• Developmental Neuroscience

Background:

• Infantile spasms (IS) are a severe epilepsy syndrome in infants.
• Adrenocorticotropic hormone (ACTH) is a first-line therapy but has limitations including incomplete efficacy, recurrence, and side effects.
• Alternative treatments like topiramate, vitamin B6, and immunoglobulin show efficacy in some cases.

Purpose of the Study:

• To evaluate the efficacy and safety of a novel polytherapy regimen for infantile spasms.
• To investigate the combined effects of adrenocorticotropic hormone, topiramate, vitamin B6, and immunoglobulin in treating West syndrome.
• To compare treatment outcomes between cryptogenic and symptomatic infantile spasms.

Main Methods:

• A prospective study involving 51 infants newly diagnosed with West syndrome.
• Administration of a four-drug polytherapy including adrenocorticotropic hormone, topiramate, vitamin B6, and immunoglobulin.
• Assessment of electroencephalographic (EEG) hypsarrhythmia, seizure control, and adverse effects.

Main Results:

• Significant improvement in EEG hypsarrhythmia was observed in a majority of patients.
• High rates of seizure freedom and low recurrence rates were achieved with the polytherapy.
• Polytherapy demonstrated superior efficacy and faster seizure control in cryptogenic infantile spasms compared to symptomatic cases.
• Adverse effects were generally mild.

Conclusions:

• Initial polytherapy with adrenocorticotropic hormone, topiramate, vitamin B6, and immunoglobulin offers an effective treatment strategy for infantile spasms.
• This combination therapy improves prognosis and reduces recurrence rates.
• The treatment appears more effective in cryptogenic infantile spasms than in symptomatic forms.